↓ Skip to main content

Dove Medical Press

Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation

Overview of attention for article published in Drug Design, Development and Therapy, February 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (86th percentile)
  • High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

news
1 news outlet
patent
1 patent

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
35 Mendeley
Title
Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation
Published in
Drug Design, Development and Therapy, February 2015
DOI 10.2147/dddt.s79343
Pubmed ID
Authors

Matthias Helmschrott, Rasmus Rivinius, Arjang Ruhparwar, Bastian Schmack, Christian Erbel, Christian A Gleissner, Mohammadreza Akhavanpoor, Lutz Frankenstein, Philipp Ehlermann, Tom Bruckner, Hugo A Katus, Andreas O Doesch

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 35 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 1 3%
Unknown 34 97%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 6 17%
Researcher 3 9%
Student > Ph. D. Student 3 9%
Other 2 6%
Student > Master 2 6%
Other 2 6%
Unknown 17 49%
Readers by discipline Count As %
Medicine and Dentistry 8 23%
Nursing and Health Professions 4 11%
Biochemistry, Genetics and Molecular Biology 1 3%
Immunology and Microbiology 1 3%
Engineering 1 3%
Other 0 0%
Unknown 20 57%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 13 December 2022.
All research outputs
#3,414,665
of 25,371,288 outputs
Outputs from Drug Design, Development and Therapy
#200
of 2,268 outputs
Outputs of similar age
#46,633
of 361,167 outputs
Outputs of similar age from Drug Design, Development and Therapy
#7
of 62 outputs
Altmetric has tracked 25,371,288 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 361,167 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 86% of its contemporaries.
We're also able to compare this research output to 62 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.